Please login to the form below

Not currently logged in
Email:
Password:

Lupin names chief corporate development officer

Theresa Stevens has experience at Novartis and Aptalis

Lupin Theresa StevensLupin has appointed Theresa Stevens as chief corporate development officer for its global operations.

Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions, strategy and global business development.

Prior to this Steven spent nine years at Novartis, serving in such roles as head of global business development and licensing.

She holds degrees in both biochemisty and law, and has previously worked as a research scientist at Dupont and as a lawyer at Pennie & Edmonds.

Lupin's decision to hire Stevens follows its appointment earlier this year of Teva's Dr Maurice Chagnaud as president, Europe, and head of inhalation strategy.

According to the company, these hires are part of a push to expand the company beyond its home market by improving its performance in the US, Europe and key emerging markets.

25th April 2014

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics